0 Commentarios
0 Acciones
652 Views
0 Vista previa
Buscar
Descubre nuevas personas, crear nuevas conexiones y hacer nuevos amigos
-
Please log in to like, share and comment!
-
Antibiotic Residue Test Kits Market Growth, Overview and Forecast Analysis By Fact.MRAntibiotic Residue Test Kits Market to Expand at a CAGR of 6.1% Through 2033, Driven by Rising Food Safety Standards and Animal-Derived Product Demand Rockville, Maryland, USA— According to Fact.MR The global antibiotic residue test kits market is witnessing steady growth momentum as food safety regulations and animal-derived food consumption intensify worldwide. According to...0 Commentarios 0 Acciones 269 Views 0 Vista previa
-
Antibiotic Stewardship Biomarkers Market Forecast and GrowthThe antibiotic stewardship biomarkers market is gaining momentum as healthcare systems worldwide focus on improving antibiotic usage and reducing the growing burden of antimicrobial resistance (AMR). Biomarkers play a crucial role in guiding clinical decisions by helping healthcare providers differentiate bacterial infections, monitor treatment responses, and optimize antibiotic therapies....0 Commentarios 0 Acciones 166 Views 0 Vista previa
-
Antibiotic Stewardship Biomarkers Market Forecast and GrowthThe antibiotic stewardship biomarkers market is gaining momentum as healthcare systems worldwide focus on improving antibiotic usage and reducing the growing burden of antimicrobial resistance (AMR). Biomarkers play a crucial role in guiding clinical decisions by helping healthcare providers differentiate bacterial infections, monitor treatment responses, and optimize antibiotic therapies....0 Commentarios 0 Acciones 176 Views 0 Vista previa
-
Global Ceftazidime Avibactam Market Insights & Growth Trends | CAGR 9.7% (2026–2034)According to a newly published market research report by 24LifeSciences, global Ceftazidime Avibactam market was valued at USD 1.2 billion in 2025 and is projected to reach USD 2.8 billion by 2034, growing at a compound annual growth rate (CAGR) of 9.7% during the forecast period 20262034. Ceftazidime Avibactam is a fixed-dose combination antibiotic incorporating ceftazidime (3rd...0 Commentarios 0 Acciones 2K Views 0 Vista previa
-
Global Ceftazidime Avibactam Market Insights & Growth Trends | CAGR 9.7% (2026–2034)According to a newly published market research report by 24LifeSciences, global Ceftazidime Avibactam market was valued at USD 1.2 billion in 2025 and is projected to reach USD 2.8 billion by 2034, growing at a compound annual growth rate (CAGR) of 9.7% during the forecast period 20262034. Ceftazidime Avibactam is a fixed-dose combination antibiotic incorporating ceftazidime (3rd...0 Commentarios 0 Acciones 2K Views 0 Vista previa
-
Global Neomycin Market Set to Reach USD 620 Million by 2034 Amid Rising Infection BurdenAccording to a new report from Intel Market Research, the global Neomycin market was valued at USD 420 million in 2025 and is projected to reach USD 620 million by 2034, growing at a steady CAGR of 4.1% during the forecast period (2026–2034). This growth is fueled by rising antibiotic demand in human healthcare and veterinary medicine, coupled with increasing prevalence of bacterial...0 Commentarios 0 Acciones 4K Views 0 Vista previa
-
Hospital-Acquired Disease Testing Market to Reach USD 724 Million by 2031 | CAGR 5.6%According to a newly published market research report by 24LifeSciences, global hospital-acquired disease testing market was valued at USD 498 million in 2024 and is projected to reach USD 724 million by 2031, growing at a compound annual growth rate (CAGR) of 5.6% during the forecast period 2026–2034. Hospital-acquired infections (HAIs), clinically significant as nosocomial...0 Commentarios 0 Acciones 3K Views 0 Vista previa